MARKET WIRE NEWS
  1. Home
  2. Stock
  3. CAPR
  4. News
CAPR
Quote
Short
News
Articles
Message Board

Capricor Therapeutics Inc. (NASDAQ : CAPR ) News

Capricor Therapeutics Inc. (NASDAQ: CAPR) News Releases

CAPR News Releases
CAPR : NASDAQ
GlobeNewswire
Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference
CAPR : NASDAQ
GlobeNewswire
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data
CAPR : NASDAQ
SeekingAlpha
Capricor Therapeutics: A High Risk/High Reward Name
CAPR : NASDAQ
Motley Fool
Here's Why This Biotechnology Skyrocketed by 439% in December
CAPR : NASDAQ
SeekingAlpha
Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy Transcript
CAPR : NASDAQ
GlobeNewswire
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy
CAPR : NASDAQ
SeekingAlpha
Capricor: A Detailed Examination Of Hope-3
CAPR : NASDAQ
KlickAnalytics
CAPR Price Target Alert: $54.00. Issued by Oppenheimer
CAPR : NASDAQ
SeekingAlpha
Capricor: Maintaining 'Hold' Rating On Randomized Phase 3 HOPE-3 Trial Win With Deramiocel
CAPR : NASDAQ
SeekingAlpha
Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Phase III Top Line Data for Deramiocel in Duchenne Muscular Dystrophy Transcript

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.